This ETF Surged While Everyone Else Struggled. How Did It Do It?
The AGFiQ U.S. Market Neutral Anti-Beta Fund managed to return 18.50% over the past quarter -- and, no, it's not an inverse or levered inverse fund.
The Market Narrative Shifted on Tuesday, So Here's How to Shift With It
It officially changed from concern over inflation and interest rates to fear of recession, which is causing a change in where traders position themselves.
An Encouraging Development in a 'Terrible' Stock Market
There's a bright spot, but it needs to be sustained.
Want a Break from Chip Stock Ugliness? Check Out This Biotech ETF and Stock
The SPDR S&P Biotech ETF is one of the better-looking charts on this trader's screen, as is an individual biotech name.
A Few Thoughts on How to Approach a Tougher Bear Market Than Most
A key goal is to keep from losing money while the current bear runs its course, and don't count on positive seasonality leading to the Fourth of July.
Welcome Break, Sellers at the Ready, Defense on Offense, GDP Sags, Yield Watch
Plus, disappointing personal spending figures and an explanation of how the Fed views inflation (hint: it isn't how you view it).
This ETF Boasts 'Inflation Protection,' but Will It Rise to the Occasion?
The Ionic Inflation Protection exchange-traded fund, the latest such ETF to hit the market, offers direct exposure to the consumer price index.
Zero-Covid? NATO's China Challenge, Quarter-End Volume, Yields, Trading Chevron
There was a time when Covid vaccine news was headline material. Not now, though, and this news could matter.
The Fed Blinked and So Did We
Here's what we need to get a bigger rally.
Man on a Mission, No Easy Recessions, Real Rotation, Retail Capitulation?
Plus, all US big banks pass the latest Fed stress test despite tougher standards, and a quick look at Dollar General.